Cargando…
PSAT307 Patient with Myxedema Coma and Subsequent Iatrogenic Thyrotoxicosis - Role of COVID-19 Pandemic
INTRODUCTION: Myxedema coma is a rare presentation of severe hypothyroidism. The low incidence of this life-threatening disease may be attributed to easy availability of TSH testing and thyroid hormone replacement therapy. Well documented cases of thyroiditis and thyrotoxicosis due to SARS-CoV-2 are...
Autores principales: | Ahmad, Manal, McCullough, Jocelyn, Quadri, Hamza, Subramaniam, Shreya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625293/ http://dx.doi.org/10.1210/jendso/bvac150.1695 |
Ejemplares similares
-
PSAT361 Severe Hyponatremia in a Patient with Myxedema Coma
por: Nemati, Maryam, et al.
Publicado: (2022) -
PSAT303 Fecal Impaction as a Gastrointestinal Prodrome of Myxedema Coma in an Elderly Woman with Multiple Co-morbidities
por: Ahmad, Mobeen, et al.
Publicado: (2022) -
Myxedema Coma Disguised as Alcohol Withdrawal
por: Pahwa, Dhivya, et al.
Publicado: (2021) -
SUN-584 Unusual Presentation Of Myxedema Coma
por: Murati, Jonila, et al.
Publicado: (2019) -
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019)